Breathing and attention training for managing fibromyalgia pain
Effects of Breathing and Attention Training (BAT) on Pain Modulation in Healthy Individuals and Patients With Chronic Musculoskeletal Pain
This study is testing whether breathing and attention training can help people with fibromyalgia manage their pain better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | University of Florida Academic / other |
| Locations | 1 site (Gainesville, Florida) |
| Trial ID | NCT05773482 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effects of Breathing and Attention Training (BAT) on pain modulation in individuals with fibromyalgia. It aims to assess how BAT, a mindfulness meditation technique, can influence pain sensitivity and overall symptoms in patients diagnosed with fibromyalgia. The study will utilize quantitative sensory testing to measure changes in pain modulation, providing a simpler and repeatable method for evaluation. Participants will include those with fibromyalgia and healthy controls for comparison.
Who should consider this trial
Good fit: Ideal candidates are individuals diagnosed with fibromyalgia experiencing chronic pain for more than six months.
Not a fit: Patients with a personal or family history of photosensitive epilepsy, prior cancer or diabetes, or those unable to discontinue certain medications may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce pain sensitivity and improve quality of life for fibromyalgia patients.
How similar studies have performed: While mindfulness techniques have shown promise in managing chronic pain, this specific approach using BAT is relatively novel and has not been extensively tested in this context.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Individuals diagnosed with fibromyalgia will have pain of duration \> 6 months and meeting the 1990 Research Diagnostic Criteria for FM (ACR) * Healthy, pain-free age matched controls without chronic pain Exclusion Criteria: * Personal or family history of photosensitive epilepsy * Prior history of cancer or diabetes * Patients must be willing to discontinue their analgesics, hypnotics, anxiolytics, or anti-depressants during the study period for at least 5 half-lives.
Where this trial is running
Gainesville, Florida
- University of Florida — Gainesville, Florida, United States (Recruiting)
Study contacts
- Principal investigator: Roland Staud, MD — University of Florida
- Study coordinator: Melyssa Godfrey
- Email: painresearch@medicine.ufl.edu
- Phone: 352-265-8901
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.